Tuesday, 25 March 2014 10:01

Anticoagulation news items. Week commencing 17th March 2014

Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients With Atrial Fibrillation

Journal of the American Medical Association

Based on a Cochrane review, this JAMA Clinical Evidence Synopsis concludes that compared with warfarin, factor Xa inhibitors are associated with a lower risk of stroke and systemic embolic events and fewer rates of intracranial haemorrhage and mortality in patients with AF.


Subdural haematoma in the elderly

British Medical Journal

This article on subdural haematoma is one of a series highlighting conditions that may be more common than many doctors realise or may be missed at first presentation. It covers how common it is, why it is missed and why this matters, and its diagnosis and management.


The young patient with asymptomatic atrial fibrillation: what is the evidence to leave the arrhythmia untreated?

European Heart Journal

This review summarises epidemiological data on young AF, efficacy, and limitations of rate and rhythm control in young patients, information on arrhythmia progression and outcome, and the consequences of these data for AF treatment in young, asymptomatic patients.


The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service.
Further details on this service can be found at: http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services